Topics
September 2016 | Special Focus: Drug Delivery
Drug Delivery to the Retina
Questions, thoughts, and opinions related to current and emerging drug delivery systems.
Timothy W. Olsen, MD
September 2015 | Special Focus: Drug Delivery
Drug Delivery to the Posterior Segment
A review of methods and technologies available and those on the horizon.
Daniel D. Esmaili, MD, and David S. Boyer, MD
November 17, 2026
MacuMira Receives CE Mark Certification for Retinal Microcurrent Stimulation Device to Treat Dry AMD
November 16, 2026
Johnson & Johnson to Acquire Ollin Biosciences for $2.2 Billion, Advancing Retinal Disease Pipeline
RetinaLyze System Receives EU MDR Class 2a Certification for Retinal Screening Software
November 11, 2026
AAO, AOA Respond to FDA GLP-1 Drug Labeling Changes, Highlight NAION Risk and Eye Care Recommendations
October 2026 Insert
Editorially Independent Content, Supported With Advertising From Asetllas
Editorially independent supported by Abbvie and Regenxbio
Supported by Zeiss
Free Print Subscription
Email Newsletter
Conference Calendar